HOUSTON, TX -- (Marketwire) -- 05/29/12 -- Z-Pak, the more common name for the antibiotic Azithromycin, is commonly used to treat middle ear infections, strep throat, and other bacterial infections. Because of the range of illnesses that it has the potential to effectively treat, Z-Pak is one of the most widely prescribed antibiotics in the world. Unfortunately, recent studies have linked this drug to the development of a number of adverse medical conditions.

It has long been known that Z-Pak is linked to gastrointestinal distress, including diarrhea and abdominal discomfort. However, a recent study published in the New England Journal of Medicine reports that Z-Pak may also be associated with an increased risk of death from cardiovascular complications. The study found that those taking Z-Pak had an elevated risk of suffering death from a heart attack or other cardiovascular issues that was 2.5 times greater than normal, for as long as they were taking the drug. For individuals with pre-existing cardiovascular problems, the risk was even greater.

Until recently, it was widely assumed that Z-Pak had no effect on the cardiovascular health of those who took it, and therefore it was common to prescribe this medication to all individuals, even those with a history of heart problems. It is important that patients and their doctors are aware of this potential danger so they can properly assess the danger when considering a course of Z-Pak or other forms of Azithromycin. The attorneys at Williams Kherkher are prepared to offer their assistance to anyone who would like more information on this issue.

About Williams Kherkher

Williams Kherkher is a mass-tort law firm based in Houston, Texas, offering legal assistance to clients nationwide. The firm handles a variety of cases, including those involving personal injury law, mesothelioma, and defective pharmaceuticals. For more information on pharmaceutical defects or other legal concerns, contact the attorneys at Williams Kherkher by calling 800-641-9810.